Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marie-José C. van Lierop"'
Autor:
Haoxiao Zuo, Marie-José C. van Lierop, Jorn Kaspers, Remco Bos, Anneke Reurs, Saheli Sarkar, Tania Konry, Alwin Kamermans, Gijs Kooij, Helga E. de Vries, Tanja D. de Gruijl, Alex Karlsson-Parra, Erik H. Manting, Ada M. Kruisbeek, Satwinder Kaur Singh
Publikováno v:
Cells, Vol 10, Iss 11, p 3233 (2021)
DCP-001 is a cell-based cancer vaccine generated by differentiation and maturation of cells from the human DCOne myeloid leukemic cell line. This results in a vaccine comprising a broad array of endogenous tumor antigens combined with a mature dendri
Externí odkaz:
https://doaj.org/article/467c11dcb8d4413a8aaeb2c376d6e894
Autor:
René J. M. Stet, Christopher J. Secombes, Marie José C. Van Lierop, John Knight, Trudi T. Hermsen, Adri Groeneveld
Publikováno v:
Fish & Shellfish Immunology. 8:231-243
A rainbow trout (Oncorhynchus mykiss) cDNA fragment encoding most of the extracellular part of the MHC class II β chain (MhcOnmy-DAB1) was cloned into a bacterial expression vector. After its purification, the recombinant protein was used for the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7ec85f8357658129cf343aeffd0f269
https://doi.org/10.1006/fsim.1997.0129
https://doi.org/10.1006/fsim.1997.0129
Autor:
Saskia H.M. van Erp, René J. M. Stet, Egbert Egberts, Pedro Rodrigues, Marie José C. Van Lierop, Brian Dixon
Publikováno v:
Fish & Shellfish Immunology. 6:305-318
Although Major Histocompatibility Complex (MHC) restricted antigen recognition was first described in the early years of the 1970s (Klein, 1986), it was not until 1987 that it became clear what the precise biochemical nature of this restriction was.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dab389e79db9957ce55fac40fcb8f9b
https://doi.org/10.1006/fsim.1996.0031
https://doi.org/10.1006/fsim.1996.0031
Autor:
Marie-José C van Lierop, Wynand Alkema, Anke J Laskewitz, Rein Dijkema, Hans M van der Maaden, Martin J Smit, Ralf Plate, Paolo G M Conti, Christan G J M Jans, C Marco Timmers, Constant A A van Boeckel, Scott J Lusher, Ross McGuire, Rene C van Schaik, Jacob de Vlieg, Ruben L Smeets, Claudia L Hofstra, Annemieke M H Boots, Marcel van Duin, Benno A Ingelse, Willem G E J Schoonen, Aldo Grefhorst, Theo H van Dijk, Folkert Kuipers, Wim H A Dokter
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48385 (2012)
Glucocorticoids (GCs) such as prednisolone are potent immunosuppressive drugs but suffer from severe adverse effects, including the induction of insulin resistance. Therefore, development of so-called Selective Glucocorticoid Receptor Modulators (SGR
Externí odkaz:
https://doaj.org/article/6e9843e211b74a5b893e7e79339992e9